 |
nintedanib |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-06 00:00:00 |
| Sponsor | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, Box 368;Ridgefield, Connecticut, 06877 |
| |
nintedanib |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-06 00:00:00 |
| Sponsor | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, Box 368;Ridgefield, Connecticut, 06877 |